Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902

Unresectable Stage ◽

Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: A retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A)

Cancer Science ◽

10.1111/j.1349-7006.2003.tb01510.x ◽

2003 ◽

Vol 94 (8) ◽

pp. 729-734 ◽

Cited By ~ 17

Author(s):

Yuichiro Ohe ◽

Naoki Ishizuka ◽

Tomohide Tamura ◽

Ikuo Sekine ◽

Yutaka Nishiwaki ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403)—Long term follow-up results.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.8512 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 8512-8512 ◽

Cited By ~ 1

Author(s):

Yasushi Nagata ◽

Masahiro Hiraoka ◽

Taro Shibata ◽

Hiroshi Onishi ◽

Masaki Kokubo ◽

...

Keyword(s):

Lung Cancer ◽

Stereotactic Body Radiation Therapy ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer; Japan Clinical Oncology Group (JCOG0403); Long Term Follow-up Results

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.06.115 ◽

2018 ◽

Vol 102 (3) ◽

pp. S9 ◽

Cited By ~ 1

Author(s):

Y. Nagata ◽

M. Hiraoka ◽

T. Shibata ◽

H. Onishi ◽

M. Kokubo ◽

...

Keyword(s):

Lung Cancer ◽

Stereotactic Body Radiation Therapy ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Final results of a phase II study of Gemcitabine (G) and Platin (P) in advanced non-small cell lung cancer (NSCLC): Long-term follow up and intention-to-treat analysis

European Journal of Cancer ◽

10.1016/s0959-8049(01)80677-8 ◽

2001 ◽

Vol 37 ◽

pp. S53

Author(s):

C. Sacco ◽

G. Cartei ◽

A. Sibau ◽

A. Bearz ◽

M. Gusella ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Intention To Treat ◽

Long Term Follow Up ◽

Treat Analysis

O-262 Concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin (V-P) in locally advanced non-small cell lung cancer. A randomized phase II study — long-term follow-up data

Lung Cancer ◽

10.1016/s0169-5002(03)91920-9 ◽

2003 ◽

Vol 41 ◽

pp. S76 ◽

Cited By ~ 9

Author(s):

Petr Zatloukal ◽

Lubos Petruzelka ◽

Milada Zemanova ◽

Libor Havel ◽

Ladislav Pecen ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Long Term Follow Up ◽

Sequential Radiochemotherapy

Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up

Oncotarget ◽

10.18632/oncotarget.16288 ◽

2017 ◽

Vol 8 (31) ◽

pp. 51848-51858 ◽

Cited By ~ 2

Author(s):

Ming Liu ◽

Zhongtang Wang ◽

Tao Zhou ◽

Antang Zhou ◽

Qian Zhao ◽

...

Keyword(s):

Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Advanced Technologies ◽

Unresectable Stage ◽

Long-Term Follow-Up of a Phase I/II Trial of Dose Escalating Three-Dimensional Conformal Thoracic Radiation Therapy with Induction and Concurrent Carboplatin and Paclitaxel in Unresectable Stage IIIA/B Non-small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e31818b1971 ◽

2008 ◽

Vol 3 (11) ◽

pp. 1279-1285 ◽

Cited By ~ 28

Author(s):

Thomas E. Stinchcombe ◽

Carrie B. Lee ◽

Dominic T. Moore ◽

M Patricia Rivera ◽

Jan Halle ◽

...

Keyword(s):

Three Dimensional ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia ◽

Unresectable Stage ◽

Thoracic Radiation ◽

Long Term Follow Up ◽

Dose Escalating

The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801

Lung Cancer ◽

10.1016/j.lungcan.2013.02.008 ◽

2013 ◽

Vol 80 (3) ◽

pp. 298-305 ◽

Cited By ~ 17

Author(s):

Yaacov Richard Lawrence ◽

Rebecca Paulus ◽

Corey Langer ◽

Maria Werner-Wasik ◽

Mark K. Buyyounouski ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Locally Advanced ◽

Radiation Therapy Oncology Group ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Randomized phase II study of sequential carboplatin plus paclitaxel and gefitinib in chemotherapy-naïve patients with advanced or metastatic non-small-cell lung cancer: Long-term follow-up results

Molecular and Clinical Oncology ◽

10.3892/mco.2016.1076 ◽

2016 ◽

Vol 6 (1) ◽

pp. 56-62

Author(s):

Emi Kubo ◽

Noboru Yamamoto ◽

Hiroshi Nokihara ◽

Yutaka Fujiwara ◽

Hidehito Horinouchi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Phase II Study of Twice-Daily High-Dose Thoracic Radiotherapy Alternating With Cisplatin and Vindesine for Unresectable Stage III Non-Small-Cell Lung Cancer: Japan Clinical Oncology Group Study 9306

Journal of Clinical Oncology ◽

10.1200/jco.20.3.797 ◽

2002 ◽

Vol 20 (3) ◽

pp. 797-803 ◽

Cited By ~ 4

Author(s):

I. Sekine

Keyword(s):

Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

High Dose ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Oncology Group Study ◽

Unresectable Stage